Member Info for banksy13

Massively de-risked now and opens up several avenues of funding going forward. Great news

Deutsche Bank raises Advanced Medical Solutions price target to 275 (250) pence - 'buy'

Results made for good reading this morning... A plan on how to get Bosch out in an orderly manner will see it back in treble figures... & a better market!

Nearly £3m in funding secured over a few days… Double the cap, don’t see that often! Let’s see what they’re lining up… Expecting news to follow shortly

Another fantastic collab for ALK... This time with a $20 billion cap company. The whole project is validated by big players.

When (not if) the funding arrives it's game on - 500p min

Bargain hunters stepping in quickly on any dips… Cheapies won’t be available much longer… Potential to the upside at 1.5m cap is massive

Defo smkr… Can sell over mid this aft. Any noise on non dilutive funding and its game on

“As we continue to gain traction, we are investigating sources of non-dilutive capital that would enable a step-change in scale. That said, our organic growth trajectory is working extremely well and we will not take undue risk. Further details of our expansion plans will be provided to shareholders in due course".

Antimony Western Europe prices now up over 10% since CMRS signed an exclusive offtake agreement in December...

'This exclusive supply agreement creates a new opportunity for CMR to occupy a space in a specialist commodities market where the supply - demand dynamic is becoming ever more problematic for Western countries'

'Antimony trading is expected to generate an above average gross profit margin when compared with other opportunities we are seeing'

Tick tock...

If it’s good enough for Schurter at 0.4p - buying at 0.16 is a gift. A bit of patience required!

Great price action... some placing shares still being flipped and traders taking profits. Good consolidation before moving in to the 20s. This makes a monumental move throughout 2025

Results due any day - Huge opportunity... Some appointment Dennis Purcell:

A pioneer in the biotechnology industry, Mr Purcell is the Founder and former Senior Managing Partner of Aisling Capital LLC ("Aisling Capital"), a leading U.S. healthcare investment firm which has raised $1.8 billion since its inception. Prior to founding Aisling Capital, Mr Purcell served as Managing Director of the Healthcare Investment Banking Group at Hambrecht & Quist (later part of JP Morgan), where he led over $20 billion in financing for the pharmaceutical, biotechnology and medical device sectors of the healthcare industry.

Dennis Purcell commented: "I am thrilled to join Graft Polymer's Board at such an exciting juncture. The Company's collaboration model, starting with Awakn, is poised to make a significant impact in the biopharmaceutical sector - specifically in the area of treating addiction and mental health issues, where there is an enormous opportunity.

The market will cotton on here soon enough... Mike is by far one of the most competent CEO's i have come across... on any low cap. Opportunities like this come around few and far between...

£4m cap... Make it make sense!!!

Pre-clinical trial results expected in a few short weeks - It's a major coup getting Dennis Purcell on board:

'Dennis is Founder and Senior Advisor at Aisling Capital LLC. During his tenure, Dennis has been directly involved with over two hundred completed transactions and supervised over $15 billion of financing and advisory assignments in the pharmaceutical, biotechnology and medical products industries'

3p+ ahead of drilling news… Volume this week compared to last has been immense

Initial discussions with LB group were based on them taking on $81m costs for a 50/50 JV... Could they come back in to the fold once the drill is turning - Cmet looking to double current NPV…. Sheffield bought 10% at 3.6p… With a further option to buy more nearer 5p…